A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer

Eur J Cancer Clin Oncol. 1986 Sep;22(9):1079-81. doi: 10.1016/0277-5379(86)90009-x.

Abstract

Forty-one patients with malignant pleural effusions secondary to breast cancer were randomly allocated to treatment with either intracavitary talc or intracavitary tetracycline. Of 33 evaluable patients, radiological control was achieved in 11/12 (92%) of the talc group compared with 10/21 (48%) of the tetracycline group (P = 0.022). Intracavitary talc provides effective palliation of metastatic pleural effusions secondary to breast cancer.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Breast Neoplasms / complications*
  • Clinical Trials as Topic
  • Humans
  • Middle Aged
  • Pleural Effusion / drug therapy
  • Pleural Effusion / etiology
  • Pleural Effusion / therapy*
  • Postoperative Complications
  • Random Allocation
  • Talc / administration & dosage
  • Talc / therapeutic use*
  • Tetracycline / therapeutic use*

Substances

  • Talc
  • Tetracycline